SE396693B - METHOD OF PREPARING COMPLEX OF SYNTHETIC CORTICOTROPINE WITH ENHANCED AND EXTENDED EFFECT - Google Patents

METHOD OF PREPARING COMPLEX OF SYNTHETIC CORTICOTROPINE WITH ENHANCED AND EXTENDED EFFECT

Info

Publication number
SE396693B
SE396693B SE7001975A SE197570A SE396693B SE 396693 B SE396693 B SE 396693B SE 7001975 A SE7001975 A SE 7001975A SE 197570 A SE197570 A SE 197570A SE 396693 B SE396693 B SE 396693B
Authority
SE
Sweden
Prior art keywords
corticotropine
enhanced
synthetic
extended effect
preparing complex
Prior art date
Application number
SE7001975A
Other languages
Swedish (sv)
Inventor
Sok
Original Assignee
Paulsen Fredrik
Paulsen Eva Wolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paulsen Fredrik, Paulsen Eva Wolf filed Critical Paulsen Fredrik
Priority to SE7001975A priority Critical patent/SE396693B/en
Priority to DE19712107282 priority patent/DE2107282A1/en
Priority to NL7102023A priority patent/NL7102023A/xx
Priority to GB2196571A priority patent/GB1345573A/en
Publication of SE396693B publication Critical patent/SE396693B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SE7001975A 1970-02-16 1970-02-16 METHOD OF PREPARING COMPLEX OF SYNTHETIC CORTICOTROPINE WITH ENHANCED AND EXTENDED EFFECT SE396693B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE7001975A SE396693B (en) 1970-02-16 1970-02-16 METHOD OF PREPARING COMPLEX OF SYNTHETIC CORTICOTROPINE WITH ENHANCED AND EXTENDED EFFECT
DE19712107282 DE2107282A1 (en) 1970-02-16 1971-02-16 Process for enhancing and prolonging the effect of synthetic corticotropin and its segment derivatives
NL7102023A NL7102023A (en) 1970-02-16 1971-02-16
GB2196571A GB1345573A (en) 1970-02-16 1971-04-19 Process for preparing a synthetic corticotropin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7001975A SE396693B (en) 1970-02-16 1970-02-16 METHOD OF PREPARING COMPLEX OF SYNTHETIC CORTICOTROPINE WITH ENHANCED AND EXTENDED EFFECT

Publications (1)

Publication Number Publication Date
SE396693B true SE396693B (en) 1977-10-03

Family

ID=20259175

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7001975A SE396693B (en) 1970-02-16 1970-02-16 METHOD OF PREPARING COMPLEX OF SYNTHETIC CORTICOTROPINE WITH ENHANCED AND EXTENDED EFFECT

Country Status (4)

Country Link
DE (1) DE2107282A1 (en)
GB (1) GB1345573A (en)
NL (1) NL7102023A (en)
SE (1) SE396693B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2758578A1 (en) * 1977-12-29 1979-07-05 Hoechst Ag STABLE SECRETARY PREPARATION, METHOD FOR THEIR PRODUCTION AND THEIR USE
US5266333A (en) * 1985-03-06 1993-11-30 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
FR2640137A1 (en) * 1988-12-08 1990-06-15 Texinfine Sa SYSTEMS CONVEYING LIPOPHILIC ACTIVE INGREDIENTS AND PROCESS FOR OBTAINING SAME
DE4224749A1 (en) * 1992-07-27 1994-02-03 Adelmann Ag Efficiently removing all blowing gases from foam plastics - by heating the material in hot air draught while it is moved by revolving screw up inclined tube, collecting and liquefying gases liberated.

Also Published As

Publication number Publication date
GB1345573A (en) 1974-01-30
DE2107282A1 (en) 1971-09-02
NL7102023A (en) 1971-08-18

Similar Documents

Publication Publication Date Title
TR19550A (en) EXCLUSIVE PROCEDURE OF POLIUERETHANE COEPUEK PLASTICS
FI54926C (en) ALKALIMETALLKARBOXYLATSALTER AV STAERKELSEPOLYAKRYLONITRILYMPKOPOLYMER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI54741B (en) ELEKTRISK KOKAPPARAT MED AOTMINSTONE EN KOKPLATTA OCH FOERFARANDE FOER TILLVERKNING AV EN SAODAN KOKAPPARAT
FI56686B (en) PROCEDURE FOR FRAMSTATION OF AV 7-AMINOCEFALOSPORANSYRADERIVAT MED ANTIBIOTIS VERKAN
BE823743Q (en) FORMATION OF TUNGSTENE AND MOLYDENE CARBIDES
SE387115B (en) METHOD OF PREPARING NITRO-IMIDAZOLES WITH ANTIMICROBIAL EFFECT
SE387525B (en) LIGHTNING AND PROCEDURE IN THE MANUFACTURE OF THE SAME
FI54316C (en) ADJUSTMENT OF ADAMOSIN-5'-CARBONSYRADERIVAT WITH KRETSOMLOPPSVERKAN
SE373578B (en) METHODS OF PRODUCING STEROIDOOXAZOLIDINES AND STEROIDO-OXAZOLIDINO-OXAZINES
FI56100B (en) LOESNINGSKONCENTRAT MED FUNGICID OCH ACARICID VERKAN
SE398119B (en) PROCEDURE FOR THE PREPARATION OF LEGRE-ALKYLFURAN-3-TIOL AND LEGRE-ALKYLDIHYDROFURAN-3-TIOL FOR USE AS A Flavorant
SE380802B (en) 3-MORFOLINO-2-CYANCACRYLAMIDE COMPOUNDS AND METHODS OF PREPARING THE SAME
SE380277B (en) METHOD OF PREPARING PHENOLHARSE FOAM FROM PHENOLESOLESHARTS AND OXALKYLED PHENOLES
FI56191B (en) FOERFARANDE FOER POLYMERISERING AV ETYLEN OCH VID FOERFARANDET ANVAENT KATALYSATORSYSTEM
SE385981B (en) WAY TO INDICATE THE NERVARENCE OF VANADIN IN AN EARTH FORMATION
BE788984A (en) 3-HYDROXYMETHYL-ISOQUINOLEINS SUBSTITUTES AND DERIVATIVES
SE396693B (en) METHOD OF PREPARING COMPLEX OF SYNTHETIC CORTICOTROPINE WITH ENHANCED AND EXTENDED EFFECT
SE393982B (en) METHOD OF PREPARING DIHYDROKINOLINE DERIVATIVES WITH ANTIOXIDING EFFECT
BE769922R (en) POLYMERCAPTO-POLYPHOSPHITES AND POLYPHOSPHATES
SE403287B (en) METHOD OF PRODUCING 1-ETHYL-IMIDAZOLES WITH ANTIMYCOTIC EFFECT
FI54620C (en) FLERSTEGSFOERFARANDE FOER BLEKNING AV CELLULOSA MED EN KLORFOERENING OCH PERAETTIKYYRA
SE396603B (en) FENAZINE DERIVATIVES WITH PLANT FUNGICID EFFECTS
SE381456B (en) METHODS OF PREPARING SUBSTITUTED 5-CYCLOHEXYL-INDANCARBONIC ACIDS AND THEIR DERIVATIVES
SE396749B (en) FENAZINE DERIVATIVES WITH PLANT FUNGICID EFFECTS
FI55639B (en) FOERFARANDE FOER FRAMSTAELLNING AV EN MED TILLSATSAEMNEN SAERSKILT ELDSKYDDSMEDEL BELAGD FIBERPRODUKT